New Rhein Healthcare Investors

What they do

New Rhein Healthcare Investors is a life sciences investment firm that applies a private equity investment approach to venture capital in healthcare. The firm focuses on late-stage, de-risked life science assets with proven clinical safety and efficacy and aims to develop products that deliver health benefits to patients and economic value to payors, while generating capital gains through strategic exits. Its team consists of seasoned executives from leading pharmaceutical and MedTech companies with experience across R&D, CMC, commercialization, and M&A, which informs sourcing, diligence, and execution.

What they look for

New Rhein Healthcare Investors focuses on late-stage, de-risked life sciences assets with proven clinical safety and efficacy, investing broadly across therapeutic areas. It applies a private equity style approach to venture capital, emphasizing product development execution and strategic exits to drive returns.

Stage

Series B+

Sectors

Healthcare

Based

Philadelphia, US